Friday, February 23, 2018 News Recap: Way to Go, Ontario! Ontario removes fibrosis requirement for HCV treatment effective Feb 28th. Action Hepatitis Canada has just shared some great news: Ontario has announced today that effective February 28, 2018, the fibrosis requirement for hepatitis C treatment will be removed! Finally, diagnosis of chronic hepatitis C and genotyping is all that will be required in Ontario to access treatment. This announcem...
An international study showed that alcohol use disorder contributed significantly to liver disease burden in patients with hepatitis C. Researchers suggest that, where appropriate, countries develop strategies that combine direct-acting antiviral therapy with management of alcohol use disorders. The study comprised 58,487 people with an HCV notification from British Columbia, 84,529 from New South Wales, and 31,924 from Scotland. Patients with alcohol
It’s no secret that excessive alcohol consumption is dangerous to the liver; that’s exactly why patients with hepatitis C are advised to steer clear of it. But more precise outcomes in this population who do partake in light-to-moderate drinking hasn’t been fully understood. A collaborative team of researchers from Belgium and Switzerland set out to find how alcohol intake and viral eradication impacted the risk of hepatocellular carcinoma (HCC), decompen
More comprehensive approaches to care needed, according to a new study in the American Journal of Preventive Medicine. Ann Arbor, MI, May 10, 2016 - Drinking alcohol can increase the risk of illness and death from the hepatitis C virus. A new national household study of U.S. adults published in the American Journal of Preventive Medicine shows that many people living with hepatitis C report either former or current excessive alcohol use. In addition,